Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Dalgleish · SciRah

Researcher profile · Semantic Scholar

A. Dalgleish

Share profile

A. Dalgleish — researcher profile on SciRah

h-index: 57
Works: 412
Citations: 16K

Most-cited papers

The Combination of Cannabidiol and Δ9-Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma Model
K. Scott, A. Dalgleish, Wai M. Liu
2014Molecular Cancer Therapeutics132 citations Open access
Semantic Scholar
Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases
M. Faries, N. Mozzillo, M. Kashani-Sabet, John F. Thompson +13 more
2017Annals of Surgical Oncology128 citations
Semantic Scholar
Mechanisms of action of tasquinimod on the tumour microenvironment
E. Raymond, A. Dalgleish, J. Damber, M. Smith +1 more
2013Cancer Chemotherapy and Pharmacology83 citations Open access
Semantic Scholar
Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia cells can be improved by altering the sequence of their administration.
K. Scott, A. Dalgleish, Wai M. Liu
2017International Journal of Oncology78 citations Open access
Semantic Scholar
Naltrexone Inhibits IL-6 and TNFα Production in Human Immune Cell Subsets following Stimulation with Ligands for Intracellular Toll-Like Receptors
Rachel Cant, A. Dalgleish, R. Allen
2017Frontiers in Immunology69 citations Open access
Semantic Scholar
Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol
J. Kenyon, Wai M. Liu, A. Dalgleish
2018Anticancer Research66 citations Open access
Semantic Scholar
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
A. Dalgleish, J. Stebbing, D. Adamson, S. Arif +19 more
2016British Journal of Cancer65 citations Open access
Semantic Scholar
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
P. Corrie, A. Marshall, P. Nathan, P. Lorigan +101 more
2018Annals of Oncology59 citations Open access
Semantic Scholar
Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients
Saif S. Ahmad, W. Qian, S. Ellis, E. Mason +25 more
2015Melanoma research54 citations Open access
Semantic Scholar
Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells
N. Ioannou, A. Seddon, A. Dalgleish, D. Mackintosh +1 more
2013BMC Cancer48 citations Open access
Semantic Scholar
Rationale for combining immunotherapy with chemotherapy.
A. Dalgleish
2015Immunotherapy45 citations
Semantic Scholar
Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma Cells.
K. Scott, J. Dennis, A. Dalgleish, Wai M. Liu
2015Anticancer Research43 citations
Semantic Scholar
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma
J. Cebon, M. Gore, John F. Thompson, I. Davis +29 more
2020Journal for ImmunoTherapy of Cancer39 citations Open access
Semantic Scholar
Surgical Management of Intraabdominal Metastases From Melanoma: Role of the Neutrophil to Lymphocyte Ratio as a Potential Prognostic Factor
F. Cananzi, A. Dalgleish, S. Mudan
2014World Journal of Surgery38 citations
Semantic Scholar
Enhancing the activity of cannabidiol and other cannabinoids in vitro through modifications to drug combinations and treatment schedules.
K. Scott, Sini Shah, A. Dalgleish, Wai M. Liu
2013Anticancer Research37 citations
Semantic Scholar
Naltrexone at low doses upregulates a unique gene expression not seen with normal doses: Implications for its use in cancer therapy.
Wai M. Liu, K. Scott, J. Dennis, Elwira Kaminska +2 more
2016International Journal of Oncology30 citations Open access
Semantic Scholar
Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity
B. Sørensen, A. Susrud, A. Dalgleish
2020QRB Discovery26 citations Open access
Semantic Scholar
Human Peritoneal Mesothelial Cells Display Phagocytic and Antigen-Presenting Functions to Contribute to Intraperitoneal Immunity
T. Shaw, Xiang Y. Zhang, Z. Huo, D. Robertson +3 more
2016International Journal of Gynecologic Cancer26 citations Open access
Semantic Scholar
Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and “New Old Friends”
T. Kleen, A. A. Galdon, A. MacDonald, A. Dalgleish
2020Frontiers in Immunology25 citations Open access
Semantic Scholar
Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibition
N. Ioannou, A. Seddon, A. Dalgleish, D. Mackintosh +2 more
2016International Journal of Oncology25 citations Open access
Semantic Scholar
Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy
P. Smith, Katarzyna Piadel, A. Dalgleish
2021Vaccines20 citations Open access
Semantic Scholar
Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2+ γδ T cell cytotoxicity in a perforin-dependent manner
D. Fowler, John P. Copier, A. Dalgleish, M. Bodman-Smith
2017Cancer Immunology and Immunotherapy20 citations Open access
Semantic Scholar
In vitro culture with gemcitabine augments death receptor and NKG2D ligand expression on tumour cells
A. Gravett, A. Dalgleish, John P. Copier
2019Scientific Reports18 citations Open access
Semantic Scholar
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two
C. Ager, M. Reilley, C. Nicholas, Todd Bartkowiak +496 more
2016Journal for ImmunoTherapy of Cancer18 citations Open access
Semantic Scholar
Effect of Gemcitabine based chemotherapy on the immunogenicity of pancreatic tumour cells and T-cells
P. Smith, Y. Yogaratnam, M. Samad, S. Kasow +1 more
2020Clinical and Translational Oncology16 citations Open access
Semantic Scholar
Enhanced effect of checkpoint inhibitors when given after or together with IMM-101: significant responses in four advanced melanoma patients with no additional major toxicity
A. Dalgleish, S. Mudan, A. Fusi
2018Journal of Translational Medicine16 citations Open access
Semantic Scholar
Developments in HIV-1 immunotherapy and therapeutic vaccination
P. Smith, H. Tanner, A. Dalgleish
2014F1000Prime Reports16 citations Open access
Semantic Scholar
Development of novel monoclonal antibodies against CD109 overexpressed in human pancreatic cancer
Gustavo A Arias-Pinilla, A. Dalgleish, S. Mudan, I. Bagwan +2 more
2018OncoTarget13 citations Open access
Semantic Scholar
The failure of radical treatments to cure cancer: can less deliver more?
A. Dalgleish, P. Stern
2018Therapeutic Advances in Vaccines and Immunotherapy13 citations Open access
Semantic Scholar
Vaccines versus immunotherapy: Overview of approaches in deciding between options
A. Dalgleish
2014Human Vaccines & Immunotherapeutics13 citations Open access
Semantic Scholar
Rituximab for treating CD20+ prostate cancer with generalized lymphadenopathy: a case report and review of the literature
A. Dalgleish, P. Featherstone, V. Vlassov, M. Rogosnitzky
2014Investigational new drugs13 citations
Semantic Scholar
Long-term survival and outcome of patients originally given Mycobacterium vaccae for metastatic malignant melanoma
F. Cananzi, S. Mudan, M. Dunne, N. Belonwu +1 more
2013Human Vaccines & Immunotherapeutics13 citations Open access
Semantic Scholar
Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer
Tanzeel Khan, A. Seddon, A. Dalgleish, Said A. Khelwatty +3 more
2020Oncology Report12 citations Open access
Semantic Scholar
The cytotoxic molecule granulysin is capable of inducing either chemotaxis or fugetaxis in dendritic cells depending on maturation: a role for Vδ2+ γδ T cells in the modulation of immune response to tumour?
E. Sparrow, D. Fowler, Joe R Fenn, Jonathan Caron +3 more
2020Immunology11 citations Open access
Semantic Scholar
Gemcitabine in the Era of Cancer Immunotherapy
Katarzyna Piadel, A. Dalgleish, P. Smith
2020Journal of clinical haematology10 citations Open access
Semantic Scholar
The importance for immunoregulation for long-term cancer control.
A. Fusi, A. Dalgleish
2017Future Oncology10 citations Open access
Semantic Scholar
Naltrexone at low doses (LDN) and its relevance to cancer therapy
Wai M. Liu, A. Dalgleish
2022Expert Review of Anticancer Therapy9 citations Open access
Semantic Scholar
A multicenter randomized, open-label, proof-of-concept, phase II trial comparing gemcitabine with and without IMM-101 in advanced pancreatic cancer.
A. Dalgleish
20159 citations
Semantic Scholar
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
P. Corrie, A. Marshall, Paul Nathan, P. Lorigan +34 more
2019Annals of Oncology8 citations Open access
Semantic Scholar
Case report on the role of radiofrequency-assisted spleen-preserving surgery for splenic metastasis in the era of check-point inhibitors
S. Mudan, Jayant Kumar, Neves C. Mafalda, T. Kusano +4 more
2017Medicine8 citations Open access
Semantic Scholar
Serum Apolipoprotein E and Other Inflammatory Markers Can Identify Non-Responding Patients to a Dendritic Cell Vaccine
Hayley Leeman, Elwira Kaminska, D. Green, M. Bodman-Smith +6 more
2018Translational Oncology7 citations Open access
Semantic Scholar
Dendritic cell phenotype can be improved by certain chemotherapies and is associated with alterations to p21waf1/cip1
Wai M. Liu, K. Scott, M. Thompson, A. Dalgleish
2013Cancer Immunology and Immunotherapy7 citations
Semantic Scholar
Revisiting the role of systemic therapies in patients with metastatic melanoma to the CNS
D. Papadatos-Pastos, A. Januszewski, A. Dalgleish
2013Expert Review of Anticancer Therapy7 citations
Semantic Scholar
The potential beneficial effects of drugs on the immune response to vaccination.
Wai M. Liu, A. Dalgleish
2012Seminars in Oncology7 citations
Semantic Scholar
Releasing the restraints of Vγ9Vδ2 T-cells in cancer immunotherapy
L. Ridgley, Jonathan Caron, A. Dalgleish, M. Bodman-Smith
2023Frontiers in Immunology6 citations Open access
Semantic Scholar
The Evidence which Suggests that This Is No Naturally Evolved Virus A Reconstructed Historical Aetiology of the SARS-CoV-2 Spike
B. Sørensen, A. Dalgleish, A. Susrud
20206 citations
Semantic Scholar
Combination Therapy in Cancer
Wai M. Liu, K. Scott, A. Dalgleish
20166 citations
Semantic Scholar
Development and application of two novel monoclonal antibodies against overexpressed CD26 and integrin α3 in human pancreatic cancer
Gustavo A Arias-Pinilla, A. Dalgleish, S. Mudan, I. Bagwan +2 more
2020Scientific Reports5 citations Open access
Semantic Scholar
The immuno-oncological implications of insulin.
G. van Niekerk, A. Dalgleish, F. Joubert, A. Joubert +1 more
2020Life Science5 citations Open access
Semantic Scholar
Long term survival in IMAGE 1 (Immune Modulation And Gemcitabine Evaluation 1), a randomized, open-label phase II trial comparing gemcitabine with and without IMM-101 in advanced pancreatic cancer.
A. Dalgleish
20155 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Wai M. Liu×10
Invite
Wai M. Liu — researcher profile on SciRah
S. Mudan×8
Invite
S. Mudan — researcher profile on SciRah
K. Scott×7
Invite
K. Scott — researcher profile on SciRah
H. Modjtahedi×5
Invite
H. Modjtahedi — researcher profile on SciRah

×4

Invite

S. Danson — researcher profile on SciRah

Invite

R. Board — researcher profile on SciRah

Invite

J. Nobes — researcher profile on SciRah

Invite

M. Harries — researcher profile on SciRah

A. Maraveyas×4

Invite

A. Maraveyas — researcher profile on SciRah

M. Middleton×4

Invite

M. Middleton — researcher profile on SciRah

John P. Copier×4

Invite

John P. Copier — researcher profile on SciRah

M. Bodman-Smith×4

Invite

M. Bodman-Smith — researcher profile on SciRah